Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis

Hepatology

Volumn 31, Issue 5, 2000, Pages 1107-1114

  Nagasue, Naofumi ^a   Dhar, Dipok Kumar ^a   Yamanoi, Akira ^a   Emi, Yamaguchi ^a   Udagawa, Jun ^a   Yamamoto, Akitaka ^a   Tachibana, Mitsuo ^a   Kubota, Hlrofumi ^a   Kohno, Hitoshi ^a   Harada, Takayuki ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN; ENDOTHELIN 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CIRRHOSIS; LYMPH FOLLICLE; MALE; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SPLENIC VEIN; SUPERIOR MESENTERIC ARTERY;

EID: 17544384380     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/he.2000.6596     Document Type: Article

References (10)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
2. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 1989;86:2863-2867.
3. Arai H, Horii S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348: 730-732.
4. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-735.
5. Levin ER. Endothelins. N Engl J Med 1995;333:356-363.
6. Housset CN, Rockey DC, Friedman SL, Bissell DM. Hepatic lipocytes: a major target for endothelin-1. J Hepatol 1995;22(Suppl 2):55-60.
7. Mallat A, Lotersztajn S. Multiple hepatic functions of endothelin-1: physiopathological relevance. J Hepatol 1996;25:405-413.
8. Rockey D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. HEPATOLOGY 1997;25:2-5.
9. Moore K, Wendon J, Frazer M, Karani J, Williams R, Bard K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992;327:1774-1778.
10. Uchihara M, Izumi N, Sato C, Maruno E Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. HEPATOLOGY 1992;16:95-99.